Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bedrocan is a private Dutch pharmaceutical cannabis company that produces standardized medicinal cannabis as active pharmaceutical ingredients and raw materials for patient treatment, clinical research, and pharmaceutical formulation development. The company operates EU-GMP-certified cultivation and manufacturing facilities in the Netherlands and Denmark, with renewed Canadian operations underway. Bedrocan is best known for supplying highly standardized cannabis flower products with defined cannabinoid and terpene profiles, including Bedrocan, Bediol, Bedica, Bedrolite, Bedrobinol, Bedropuur, and Bedrolina. Its products are distributed through regulated medicinal cannabis channels and used by governments, pharmacies, researchers, and pharmaceutical manufacturers. The company also conducts clinical and analytical research focused on the medical use of cannabis and quality standardization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bedrocan.